Toshiaki Amamoto

749 citations
21 papers · 578 indexed · h-index 14
Topics
Sesquiterpenes and Asteraceae Studies (4 papers)Pharmacological Effects and Toxicity Studies (3 papers)Bioactive Compounds and Antitumor Agents (2 papers)
Partner nations
JapanUnited States

In The Last Decade

Toshiaki Amamoto

20 papers receiving 573 citations

Peers

Toshiaki Amamoto
Comparison fields: 5 of 84
  • Molecular Biology 162
  • Pharmacology 135
  • Pharmacology 90
  • Surgery 81
  • Nutrition and Dietetics 77
Replace Michinaga Matsumoto with:
Michinaga Matsumoto Japan
Benrong Hu China
Masaaki Tomoi Japan
Shigenobu Ueda Japan
Koji Ueshima Japan
I. Grattagliano Italy
Yoichiro Nakai Japan
Caner Günaydın Türkiye
De‐Jian Jiang China
Deepshikha Pande Katare India
Toshiaki Amamoto relative to Michinaga Matsumoto Japan Michinaga Matsumoto's profile →
Citations per field
00.5×1.5×2.1×
Michinaga Matsumoto · 1×
Citations per year

Countries citing papers authored by Toshiaki Amamoto

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Amamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Amamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Amamoto more than expected).

Fields of papers citing papers by Toshiaki Amamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Amamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Amamoto. The network helps show where Toshiaki Amamoto may publish in the future.

Co-authorship network of co-authors of Toshiaki Amamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Amamoto. A scholar is included among the top collaborators of Toshiaki Amamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Amamoto. Toshiaki Amamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 21
2 4
3 46
4 27
5 18
6 19
7 72
8 34
9 18
10 21
11
17
12 1
13
[Relationship between hippocampal arachidonic acid content and induction of LTP in aged rats].
5
14 28
15 77
16 105
17 9
18
Tazobactam/piperacillin (TAZ/PIPC): Phase I clinical trial
2
19 1
20
[Clinical experience of sisomicin sulfate by intravenous drip infusion for the treatment of infection complicated by malignant disease].
0

About Toshiaki Amamoto

Toshiaki Amamoto is a scholar working on Toxicology, Pharmacology and Biochemistry, having authored 21 papers that have together received 578 indexed citations. Recurring topics across this work include Sesquiterpenes and Asteraceae Studies (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Pharmacology (90 citations), Pharmacology (135 citations) and Gastroenterology (42 citations). Toshiaki Amamoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Hironori Aramaki, Shuso Takeda, Yoshiko Okamoto, Curtis J. Omiecinski, Hiroko Miyoshi, Kazuhito Watanabe, Kazutaka Yoshida, Mitsuko Okada, Akinori Urae and M. Fujiwara. Their work appears in journals such as Journal of Biological Chemistry, Neuroscience and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026